Diagnostic and prognostic value of glycosyltransferase mRNA in glioblastoma multiforme patients

Neuropathology and Applied Neurobiology

Volumn 32, Issue 4, 2006, Pages 410-418

  Oblinger, J L ^a   Pearl, D K ^a   Boardman, C L ^b   Saqr, H ^a   Prior, T W ^a   Scheithauer, B W ^c   Jenkins, R B ^c   Burger, P C ^d   Yates, A J ^a,e  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MAINE   (United States)

^c MAYO CLINIC   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Division of Neuropathology   (United States)

Author keywords

Diagnosis; Gangliosides; Glioblastoma multiforme; Glycosyltransferases; Prognosis; Real time reverse transcription polymerase chain reaction

Indexed keywords

GALACTOSYLTRANSFERASE; GANGLIOSIDE GM1; GLYCOSYLTRANSFERASE; MESSENGER RNA;

ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DIAGNOSTIC VALUE; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL;

BRAIN NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; GLIOBLASTOMA; GLIOMA; GLYCOSYLTRANSFERASES; HUMANS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 33745739440     PISSN: 03051846     EISSN: 13652990     Source Type: Journal    
DOI: 10.1111/j.1365-2990.2006.00742.x     Document Type: Article

References (34)

1. Aldape KD, Okcu MF, Bondy ML, Wrensch M. Molecular epidemiology of glioblastoma. Cancer J 2003; 9: 99-106
2. Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, Cavenee WK, DePinho RA. Malignant glioma: genetics and biology of a grave matter. Genes Dev 2001; 15: 1311-33
3. McLendon RE, Halperin EC. Is the long-term survival of patients with intracranial glioblastoma multiforme overstated? Cancer 2003; 98: 1745-8
4. Surawicz TS, Davis F, Freels S, Laws ER Jr, Menck HR. Brain tumor survival: results from the National Cancer Data Base. J Neurooncol 1998; 40: 151-60
5. Birkle S, Zeng G, Gao L, Yu RK, Aubry J. Role of tumor-associated gangliosides in cancer progression. Biochimie 2003; 85: 455-63
6. Berra B, Gaini SM, Riboni L. Correlation between ganglioside distribution and histological grading of human astrocytomas. Int J Cancer 1985; 36: 363-6
7. Koochekpour S, Pilkington GJ. Vascular and perivascular GD3 expression in human glioma. Cancer Lett 1996; 104: 97-102
8. von Holst H, Nygren C, Bostrom K, Collins VP, Fredman P. The presence of foetal ganglioside antigens 3′-isoLM1 and 3′6′-isoLD1 in both glioma tissue and surrounding areas from human brain. Acta Neurochir (Wien) 1997; 139: 141-5
9. Comas TC, Tai T, Kimmel D, Scheithauer BW, Burger PC, Pearl DK, Jewell SD, Yates AJ. Immunohistochemical staining for ganglioside GD1b as a diagnostic and prognostic marker for primary human brain tumors. Neuro-Oncol 1999; 1: 261-7
10. Aldape K, Ginzinger DG, Godfrey TE. Real-time quantitative polymerase chain reaction: a potential tool for genetic analysis in neuropathology. Brain Pathol 2002; 12: 54-66
11. Aldred MA, Ginn-Pease ME, Morrison CD, Popkie AP, Gimm O, Hoang-Vu C, Krause U, Dralle H, Jhiang SM, Plass C, Eng C. Caveolin-1 and caveolin-2, together with three bone morphogenetic protein-related genes, may encode novel tumor suppressors down-regulated in sporadic follicular thyroid carcinogenesis. Cancer Res 2003; 63: 2864-71
12. Burton EC, Lamborn KR, Feuerstein BG, Prados M, Scott J, Forsyth P, Passe S, Jenkins RB, Aldape KD. Genetic aberrations defined by comparative genomic hybridization distinguish long-term from typical survivors of glioblastoma. Cancer Res 2002; 62: 6205-10
13. Hakin-Smith V, Jellinek DA, Levy D, Carroll T, Teo M, Timperley WR, McKay MJ, Reddel RR, Royds JA. Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme. Lancet 2003; 361: 836-8
14. Korshunov A, Golanov A, Sycheva R. Immunohistochemical markers for prognosis of oligodendroglial neoplasms. J Neurooncol 2002; 58: 237-53
15. Simmons ML, Lamborn KR, Takahashi M, Chen P, Israel MA, Berger MS, Godfrey T, Nigro J, Prados M, Chang S, Barker FG 2nd, Aldape K. Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients. Cancer Res 2001; 61: 1122-8
16. Becker R, Rohlfs J, Jennemann R, Wiegandt H, Mennel HD, Bauer BL. Glycosphingolipid component profiles or human gliomas - correlation to survival time and histopathological malignancy grading. Clin Neuropathol 2000; 19: 119-25
17. Bieberich E, Freischutz B, Liour SS, Yu RK. Regulation of ganglioside metabolism by phosphorylation and dephosphorylation. J Neurochem 1998; 71: 972-9
18. Sung CC, Pearl DK, Coons SW, Scheithauer BW, Johnson PC, Yates AJ. Gangliosides as diagnostic markers of human astrocytomas and primitive neuroectodermal tumors. Cancer 1994; 74: 3010-22
19. Farooqui T, Kelley T, Coggeshall KM, Rampersaud AA, Yates AJ. GM1 inhibits early signaling events mediated by PDGF receptor in cultured human glioma cells. Anticancer Res 1999; 19: 5007-13
20. Van Brocklyn J, Bremer EG, Yates AJ. Gangliosides inhibit platelet-derived growth factor-stimulated receptor dimerization in human glioma U-1242MG and Swiss 3T3 cells. J Neurochem 1993; 61: 371-4
21. Yates AJ, Saqr HE, Van Brocklyn J. Ganglioside modulation of the PDGF receptor. A model for ganglioside functions. J Neurooncol 1995; 24: 65-73
22. De Maria R, Lenti L, Malisan F, d'Agostino F, Tomassini B, Zeuner A, Rippo MR, Testi R. Requirement for GD3 ganglioside in CD95- and ceramide-induced apoptosis.[erratum appears in Science 1998 April 17; 280(5362): 363]. Science 1997; 277: 1652-5
23. Giammarioli AM, Garofalo T, Sorice M, Misasi R, Gambardella L, Gradini R, Fais S, Pavan A, Malorni W. GD3 glycosphingolipid contributes to Fas-mediated apoptosis via association with ezrin cytoskeletal protein, [erratum appears in FEBS Lett 2001 November 23; 508(3): 494]. FEBS Lett 2001; 506: 45-50
24. Kristal BS, Brown AM. Apoptogenic ganglioside GD3 directly induces the mitochondrial permeability transition. J Biol Chem 1999; 274: 23169-75
25. Malisan F, Testi R. GD3 ganglioside and apoptosis. Biochim Biophys Acta 2002; 1585: 179-87
26. Malisan F, Testi R. GD3 in cellular ageing and apoptosis. Exp Gerontol 2002; 37: 1273-82
27. Saqr HE, Omran OM, Dasgupta S, Yu RK, Oblinger UL, Yates AJ. Endogenous GD3 ganglioside induces apoptosis in U-1242 MG glioma cells. J Neurochem; 96: 1301-14
28. Meuillet EJ, Mania-Farnell B, George D, Inokuchi JI, Bremer EG. Modulation of EGF receptor activity by changes in the GM3 content in a human epidermoid carcinoma cell line, A431. Exp Cell Res 2000; 256: 74-82
29. Rebbaa A, Hurh J, Yamamoto H, Kersey DS, Bremer EG. Ganglioside GM3 inhibition of EGF receptor mediated signal transduction. Glycobiology 1996; 6: 399-406
30. Bigner SH, Burger PC, Wong AJ, Werner MH, Hamilton SR, Muhlbaier LH, Vogelstein B, Bigner DD. Gene amplification in malignant human gliomas: clinical and histopathologic aspects. J Neuropathol Exp Neurol 1988; 47: 191-205
31. Bigner SH, Humphrey PA, Wong AJ, Vogelstein B, Mark J, Friedman HS, Bigner DD. Characterization of the epidermal growth factor receptor in human glioma cell lines and xenografts. Cancer Res 1990; 50: 8017-22
32. Ekstrand AJ, James CD, Cavenee WK, Seliger B, Pettersson RF, Collins VP. Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo. Cancer Res 1991; 51: 2164-72
33. Humphrey PA, Wong AJ, Vogelstein B, Friedman HS, Werner MH, Bigner DD, Bigner SH. Amplification and expression of the epidermal growth factor receptor gene in human glioma xenografts. Cancer Res 1988; 48: 2231-8
34. Noll EN, Lin J, Nakatsuji Y, Miller RH, Black PM. GM3 as a novel growth regulator for human gliomas. Exp Neurol 2001; 168: 300-9